SyntheticGestalt develops machine learning models for drug discovery and software for facilitating and automating research.
SyntheticGestalt has raised $1.0M in total funding. The most recent round was Non-equity Assistance. The last funding was announced in October 2025.
SyntheticGestalt's investors include Incubate Fund, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), Amazon Web Services, Headline Asia (formerly Infinity Ventures), The Future Fund.
SyntheticGestalt is headquartered in Tokyo, Japan.
SyntheticGestalt develops machine learning models for drug discovery and software for facilitating and automating research.
SyntheticGestalt is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SyntheticGestalt — Funding & Investors." VCBacked, October 8, 2025, https://www.vcbacked.co/company/syntheticgestalt. Accessed July 20, 2026.
VCBacked. (2025). SyntheticGestalt — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/syntheticgestalt
{{cite web |title=SyntheticGestalt — Funding & Investors |url=https://www.vcbacked.co/company/syntheticgestalt |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated